- Home
- IXHL vs ATCH Comparison
IXHL vs ATCH Comparison
Compare IXHL & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- ATCH
- Stock Information
- Founded
- IXHL 2001
- ATCH 2022
- Country
- IXHL Australia
- ATCH United States
- Employees
- IXHL N/A
- ATCH N/A
- Industry
- IXHL
- ATCH
- Sector
- IXHL
- ATCH
- Exchange
- IXHL Nasdaq
- ATCH Nasdaq
- Market Cap
- IXHL 49.1M
- ATCH 39.9M
- IPO Year
- IXHL N/A
- ATCH N/A
- Fundamental
- Price
- IXHL $0.35
- ATCH $0.31
- Analyst Decision
- IXHL
- ATCH
- Analyst Count
- IXHL 0
- ATCH 0
- Target Price
- IXHL N/A
- ATCH N/A
- AVG Volume (30 Days)
- IXHL 22.0M
- ATCH 17.6M
- Earning Date
- IXHL 11-14-2025
- ATCH 11-14-2025
- Dividend Yield
- IXHL N/A
- ATCH N/A
- EPS Growth
- IXHL N/A
- ATCH N/A
- EPS
- IXHL N/A
- ATCH N/A
- Revenue
- IXHL $12,000.00
- ATCH $12,303,120.00
- Revenue This Year
- IXHL $1,188.37
- ATCH N/A
- Revenue Next Year
- IXHL N/A
- ATCH N/A
- P/E Ratio
- IXHL N/A
- ATCH N/A
- Revenue Growth
- IXHL N/A
- ATCH 80.78
- 52 Week Low
- IXHL $0.08
- ATCH $0.14
- 52 Week High
- IXHL $2.65
- ATCH $18.33
- Technical
- Relative Strength Index (RSI)
- IXHL 43.91
- ATCH 42.23
- Support Level
- IXHL $0.35
- ATCH $0.30
- Resistance Level
- IXHL $0.38
- ATCH $0.36
- Average True Range (ATR)
- IXHL 0.03
- ATCH 0.04
- MACD
- IXHL 0.01
- ATCH -0.00
- Stochastic Oscillator
- IXHL 19.41
- ATCH 4.82
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.